Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

SELL
$7.14 - $8.53 $477,451 - $570,401
-66,870 Reduced 23.05%
223,270 $1.61 Million
Q4 2022

Feb 14, 2023

BUY
$8.22 - $10.76 $161,687 - $211,649
19,670 Added 7.27%
290,140 $2.39 Million
Q3 2022

Nov 18, 2022

BUY
$8.95 - $12.0 $104,356 - $139,920
11,660 Added 4.51%
270,470 $2.86 Million
Q2 2022

Aug 10, 2022

BUY
$6.46 - $10.02 $1.67 Million - $2.59 Million
258,810 New
258,810 $2.39 Million

Others Institutions Holding BLU

# of Institutions
1
Shares Held
128K
Call Options Held
0
Put Options Held
0

About BELLUS Health Inc.


  • Ticker BLU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,793,000
  • Description
  • BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...
More about BLU
Track This Portfolio

Track Industrial Alliance Investment Management Inc. Portfolio

Follow Industrial Alliance Investment Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Industrial Alliance Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Industrial Alliance Investment Management Inc. with notifications on news.